James Chen, CMT is an expert trader, investment adviser, and global market strategist. Khadija Khartit is a strategy, investment, and funding expert, and an educator of fintech and strategic finance ...

BEDFORD, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to ...

The U.S. Food and Drug Administration (FDA) has introduced a new pilot program to prioritize Abbreviated New Drug Applications (ANDAs) for generic drugs that utilize U.S.-based manufacturing and ...

Amid President Donald Trump’s efforts to onshore drug manufacturing and lower drug prices, the US Food and Drug Administration (FDA) has debuted a new pilot scheme aimed at fast-tracking generic ...

SUNRISE, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, ...

ANN ARBOR, Mich., July 08, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Accord Healthcare Inc. This agreement resolves the ...

Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.

The pharma giant has officially secured USFDA approval for its generic version of the seizure medication Brivaracetam.

Lupin receives USFDA approval for generic Brivaracetam Oral Solution to treat seizures, initiating its U.S. market launch.

Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration (FDA) has introduced the abbreviated new drug application (ANDA) scheme Amid President Donald ...

Alembic Pharmaceuticals has received final approval from the USFDA for its Lamotrigine orally disintegrating tablets used in the treatment of various seizure disorders.